Search - tctmd.com

Displaying 1 - 20 of 73

Sort: Relevancy | Date

News Conference News CX Symposium 2025

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

L.A. McKeown

April 30, 2025

News Daily News

Survey Calls Out Implicit Bias in Peripheral Vascular Care

L.A. McKeown

February 28, 2025

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

L.A. McKeown

July 24, 2024

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

News Conference News ISET 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Caitlin E. Cox

January 24, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Conference News VIVA 2022

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

L.A. McKeown

November 04, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

Advertisement

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

Survey Calls Out Implicit Bias in Peripheral Vascular Care

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

May 2024 Dispatch for the CV Team

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

January 2024 Dispatch for the CV Team

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content